Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.200
+0.360 (9.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed
IMDX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 4.05 | 1.88 | 1.5 | 0.96 | 2.2 | Upgrade
|
| Revenue Growth (YoY) | 115.58% | 25.15% | 56.89% | -56.42% | 80.76% | Upgrade
|
| Cost of Revenue | 1.75 | 1.05 | 1 | 0.88 | 0.7 | Upgrade
|
| Gross Profit | 2.31 | 0.83 | 0.5 | 0.08 | 1.5 | Upgrade
|
| Selling, General & Admin | 16.98 | 14.15 | 13.54 | 21.53 | 20.39 | Upgrade
|
| Research & Development | 15.82 | 9.84 | 9.15 | 7.28 | 4.8 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.01 | 0.09 | 0.09 | 0.1 | 0.08 | Upgrade
|
| Operating Expenses | 32.8 | 24.08 | 22.77 | 28.91 | 25.28 | Upgrade
|
| Operating Income | -30.5 | -23.25 | -22.27 | -28.83 | -23.77 | Upgrade
|
| Interest Expense | -0.11 | -0.08 | -0.05 | -0.08 | -0.21 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.01 | 0.46 | 0.39 | -0.06 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | -29.59 | -22.87 | -21.93 | -28.98 | -24.29 | Upgrade
|
| Merger & Restructuring Charges | -0.08 | - | -0.59 | -1.5 | -2.69 | Upgrade
|
| Impairment of Goodwill | - | - | - | -18.68 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.06 | -0.47 | 0.23 | Upgrade
|
| Asset Writedown | -14.6 | -42.07 | -8.04 | - | - | Upgrade
|
| Other Unusual Items | -5.95 | 4.28 | 5.76 | 31.02 | -26.13 | Upgrade
|
| Pretax Income | -50.22 | -60.66 | -24.86 | -18.61 | -52.87 | Upgrade
|
| Income Tax Expense | - | - | - | - | -9.26 | Upgrade
|
| Earnings From Continuing Operations | -50.22 | -60.66 | -24.86 | -18.61 | -43.61 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -2.93 | -54.29 | -20.49 | Upgrade
|
| Net Income | -50.22 | -60.66 | -27.78 | -72.9 | -64.1 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 0.26 | 0.94 | 0.52 | - | Upgrade
|
| Net Income to Common | -50.22 | -60.93 | -28.72 | -73.42 | -64.1 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 13 | 8 | 6 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 13 | 8 | 6 | 4 | Upgrade
|
| Shares Change (YoY) | 133.16% | 70.84% | 38.10% | 24.61% | 35.80% | Upgrade
|
| EPS (Basic) | -1.65 | -4.66 | -3.75 | -13.25 | -14.42 | Upgrade
|
| EPS (Diluted) | -1.65 | -4.66 | -3.75 | -13.25 | -14.42 | Upgrade
|
| Free Cash Flow | -25.37 | -21.21 | -23.61 | -49.91 | -38.19 | Upgrade
|
| Free Cash Flow Per Share | -0.83 | -1.62 | -3.08 | -9.01 | -8.59 | Upgrade
|
| Gross Margin | 56.84% | 44.02% | 33.33% | 8.14% | 68.29% | Upgrade
|
| Operating Margin | -752.03% | -1235.88% | -1481.57% | -3009.50% | -1081.62% | Upgrade
|
| Profit Margin | -1238.52% | -3239.02% | -1911.05% | -7664.09% | -2916.15% | Upgrade
|
| Free Cash Flow Margin | -625.62% | -1127.33% | -1570.59% | -5209.60% | -1737.40% | Upgrade
|
| EBITDA | -28.3 | -21.68 | -20.59 | -23.61 | -19.57 | Upgrade
|
| D&A For EBITDA | 2.2 | 1.56 | 1.68 | 5.22 | 4.21 | Upgrade
|
| EBIT | -30.5 | -23.25 | -22.27 | -28.83 | -23.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.